Athira Pharma Inc
Change company Symbol lookup
Select an option...
ATHA Athira Pharma Inc
NKRKY Nokian Tyres plc
USEG US Energy Corp
RENO Renovare Environmental Inc
CRT Cross Timbers Royalty Trust
LUV Southwest Airlines Co
AVA Avista Corp
NJR New Jersey Resources Corp
GAMCU Golden Arrow Merger Corp
OTMOW Otonomo Technologies Equty Warrant Exp 13th Aug 2026 *W EXP 08/13/2026
Go

Health Care : Pharmaceuticals |
Company profile

Athira Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing small molecules to restore neuronal health and stop neurodegeneration. The Company's lead candidate, fosgonimeton (ATH-1017), is a subcutaneously administered, blood brain barrier (BBB)-penetrating, small molecule HGF/MET positive modulator. The primary target indication is Alzheimers disease. The ATH-1017, is a subcutaneous administered, BBB-penetrating, small molecule hepatocyte growth factor/mesenchymal-epithelial transition factor (HGF/MET) activator for the treatment of neurodegenerative disorders, with an initial focus on Alzheimer's disease (AD). It also has preclinical candidates for non-AD indications, including ATH-1018, which is being developed to address peripheral indications, and ATH-1019/ATH-1020 compounds, which are being advanced to address neuropsychiatric indications. ATH technology is designed to promote HGF/MET activity for a variety of clinical applications.

Closing Price
$3.22
Day's Change
0.17 (5.57%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.32
Day's Low
3.01
Volume
(Light)
Volume:
2,372,772

10-day average volume:
3,705,442
2,372,772
  • Prev Close
    3.05
  • Today's Open
    3.10
  • Day's Range
    3.01-3.32
  • Avg Vol (10-day)
    3.7M
  • Last (time)
    4:00p ET 07/01/22
  • Last (size)
    836
  • 52-Wk Range
    2.53 - 16.65
    LowHigh
  • (11/12/21 - 06/22/22)
    27.27%
  • 122.8%
  • Market Cap
    121.2M
  • Shares Outstanding
    37.6M
  • -1.72
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 73.26
  • (% of float 06/15/22)
    9.71

Latest News

June 22, 2022
4:36 pm ET
MarketWatch
1:29 pm ET
MarketWatch
8:25 am ET
MarketWatch
7:00 am ET
Globe Newswire
June 07, 2022
7:00 am ET
Globe Newswire
May 27, 2022
10:50 pm ET
BusinessWire
May 20, 2022
9:00 pm ET
BusinessWire
May 19, 2022
12:06 pm ET
Globe Newswire
May 16, 2022
4:49 pm ET
Globe Newswire
8:00 am ET
BusinessWire
7:00 am ET
Globe Newswire
May 13, 2022
10:50 pm ET
PR Newswire
May 12, 2022
4:05 pm ET
Globe Newswire
8:00 am ET
BusinessWire
May 11, 2022
4:15 pm ET
Globe Newswire
May 09, 2022
7:22 am ET
Globe Newswire
May 05, 2022
3:06 pm ET
BusinessWire
12:03 pm ET
Globe Newswire
8:00 am ET
Globe Newswire
7:30 am ET
BusinessWire
May 04, 2022
6:46 pm ET
Globe Newswire
7:00 am ET
BusinessWire
April 29, 2022
10:50 pm ET
BusinessWire
April 26, 2022
8:00 am ET
Globe Newswire
April 20, 2022
9:02 am ET
Globe Newswire
April 15, 2022
9:00 pm ET
BusinessWire
April 05, 2022
4:04 pm ET
Globe Newswire
April 04, 2022
7:00 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.